Pulmonary disposition of tilmicosin in foals and in vitro activity against Rhodococcus equi and other common equine bacterial pathogens

Journal of Veterinary Pharmacology and Therapeutics

Volumn 29, Issue 6, 2006, Pages 561-568

  Womble, A ^a   Giguere S ^a   Murthy, Y V S N ^b   Cox, C ^b   Obare, E ^b  

^a University of Florida College of Veterinary Medicine   (United States)

^b Idexx Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TILMICOSIN;

ACTINOBACILLUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL VIRULENCE; BODY WEIGHT; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; ENTEROBACTERIACEAE; ENTEROCOCCUS; FEMALE; HALF LIFE TIME; HORSE; IN VITRO STUDY; LUNG ALVEOLUS CELL; LUNG FLUID; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MINIMUM INHIBITORY CONCENTRATION; NEUTROPHIL; NONHUMAN; PASTEURELLA; PRIORITY JOURNAL; PSEUDOMONAS;

ANIMALS; ANIMALS, NEWBORN; AREA UNDER CURVE; BRONCHOALVEOLAR LAVAGE; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HORSES; LUNG; MACROLIDES; MALE; MICROBIAL SENSITIVITY TESTS; RHODOCOCCUS EQUI; TYLOSIN;

ACTINOBACILLUS; BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; ENTEROCOCCUS; EQUIDAE; PASTEURELLA; PSEUDOMONAS; RHODOCOCCUS EQUI; STAPHYLOCOCCUS;

EID: 33750576848     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2006.00804.x     Document Type: Article

References (45)

1. Baldwin, D.R., Honeybourne, D. & Wise, R. (1992) Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrobial Agents and Chemotherapy, 36, 1171-1175.
2. Bowersock, T.L., Salmon, S.A., Portis, E.S., Prescott, J.F., Robison, D.A., Ford, C.W. & Watts, J.L. (2000) MICs of oxazolidinones for Rhodococcus equi strains isolated from humans and animals. Antimicrobial Agents and Chemotherapy, 44, 1367-1369.
3. Clark, C. & Dowling, P.M. (2005) Antimicrobial-associated diarrhea in horses. Proceedings of the 23rd ACVIM Forum. pp. 169-171. Baltimore, MD.
4. Clark, C., Woodbury, M., Dowling, P., Ross, S. & Boison, J.O. (2004) A preliminary investigation of the disposition of tilmicosin residues in elk tissues and serum. Journal of Veterinary Pharmacology and Therapeutics, 27, 385-387.
5. Cohen, N.D. (1994) Causes of and farm management factors associated with disease and death in foals. Journal of the American Veterinary Medical Association, 204, 1644-1651.
6. Conte, J.E., Golden, J., Duncan, S., McKenna, E., Lin, E. & Zurlinden, E. (1996) Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. Antimicrobial Agents and Chemotherapy, 40, 1617-1622.
7. Croft, A., Duffield, T., Menzies, P., Leslie, K., Bagg, R. & Dick, P. (2000) The effect of tilmicosin administered to ewes prior to lambing on incidence of clinical mastitis and subsequent lamb performance. Canadian Veterinary Journal, 41, 306-311.
8. Davis, J.L., Gardner, S.Y., Jones, S.L., Schwabenton, B.A. & Papich, M.G. (2002) Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes. Journal of Veterinary Pharmacology and Therapeutics, 25, 99-104.
9. DeRosa, D.C., Veenhuizen, M.F., Bade, D.J. & Shryock, T.R. (2000) In vitro susceptibility of porcine respiratory pathogens to tilmicosin. Journal of Veterinary Diagnostic Investigation, 12, 541-546.
10. Dingwell, R.T., Leslie, K.E., Duffield, T.F. et al. (2003) Efficacy of intramammary tilmicosin and risk factors for cure of Staphylococcus aureus infection in the dry period. Journal of Dairy Science, 86, 159-168.
11. Drusano, G.L. (2005) Infection site concentrations: their therapeutic importance and the macrolide and macrolide-like class of antibiotics. Pharmacotherapy, 25, 150S-158S.
12. Elanco Animal Health (1995a) Micotil 300 Injection. Tilmicosin Phosphate. Manufacturer's drug insert (revised October, 1995), Indianapolis, IN.
13. Elanco Animal Health (1995b) Pulmotil 90 Feed Additive. Manufacturer's drug insert (revised February, 1995), Indianapolis, IN.
14. Fietta, A., Merlini, C. & Gialdroni, G.G. (1997) Requirements for intracellular accumulation and release of clarithromycin and azithromycin by human phagocytes. Journal of Chemotherapy, 9, 23-31.
15. Gibaldi, M. & Perrier, D. (1982) Noncompartmental analysis based on statistical moment theory. In Pharmacokinetics, 2nd edn. Eds Gibaldi, M. & Perrier, D. pp. 409-417. Marcel Dekker, New York.
16. Giguère, S., Gaskin, J.M., Miller, C. & Bowman, J.L. (2002) Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals. Journal of the American Veterinary Medical Association, 220, 59-63.
17. Giguère, S., Jacks, S., Roberts, G.D., Hernandez, J., Long, M.T. & Ellis, C. (2004) Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia. Journal of Veterinary Internal Medicine, 18, 568-573.
18. Hillidge, C.J. (1987) Use of erythromycin-rifampin combination in treatment of Rhodococcus equi pneumonia. Veterinary Microbiology, 14, 337-342.
19. Hoffman, A.M., Viel, L., Prescott, J.F., Rosendal, S. & Thorsen, J. (1993) Association of microbiologic flora with clinical, endoscopic, and pulmonary cytologic findings in foals with distal respiratory tract infection. American Journal of Veterinary Research, 54, 1615-1622.
20. Jacks, S., Giguère, S., Gronwall, R.R., Brown, M.P. & Merritt, K.A. (2001) Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals. American Journal of Veterinary Research, 62, 1870-1875.
21. Kempf, I., Reeve-Johnson, L., Gesbert, F. & Guittet, M. (1997) Efficacy of tilmicosin in the control of experimental Mycoplasma gallisepticum infection in chickens. Avian Disease, 41, 802-807.
22. Kordick, D.L., Murthy, Y. & Henley, K. (2003) Biodistribution of a Novel Formulation of Tilmicosin in Cats, American Society for Microbiology, 103rd general meeting, Washington D.C. Abstract Z014, pp. 94.
23. Main, B.W., Means, J.R., Rinkema, L., Smith, W.C. & Sarazan, R.D. (1996) Cardiovascular effects of the macrolide antibiotic tilmicosin, administered alone and in combination with propranolol or dobutamine, in conscious unrestrained dogs. Journal of Veterinary Pharmacology and Therapeutics, 19, 225-232.
24. Mandell, G.L. & Coleman, E. (2001) Uptake, transport, and delivery of antimicrobial agents by human polymorphonuclear neutrophils. Antimicrobial Agents and Chemotherapy, 45, 1794-1798.
25. McKay, S.G., Morck, D.W., Merrill, J.K., Olson, M.E., Chan, S.C. & Pap, K.M. (1996) Use of tilmicosin for treatment of pasteurellosis in rabbits. American Journal of Veterinary Research, 57, 1180-1184.
26. Modric, S., Webb, A.I. & Derendorf, H. (1998) Pharmacokinetics and pharmacodynamics of tilmicosin in sheep and cattle. Journal of Veterinary Pharmacology and Therapeutics, 21, 444-452.
27. Modric, S., Webb, A.I. & Davidson, M. (1999) Effect of respiratory tract disease on pharmacokinetics of tilmicosin in rats. Laboratory Animal Science, 49, 248-253.
28. Musser, J., Mechor, G.D., Grohn, Y.T., Dubovi, E.J. & Shin, S. (1996) Comparison of tilmicosin with long-acting oxytetracycline for treatment of respiratory tract disease in calves. Journal of the American Veterinary Medical Association, 208, 102-106.
29. National Committee for Clinical Laboratory Standards (1999a) Methods for Determining Bactericidal Activity of Antimicrobial Agents; Approved Guidelines. NCCLS document M26-A, Wayne, PA.
30. National Committee for Clinical Laboratory Standards (1999b) Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals; Approved Standards. NCCLS document M31-A, Wayne, PA.
31. National Committee for Clinical Laboratory Standards (2002) Performance Standards for Antimicrobial Susceptibility Testing; Twelfth Informational Supplement; Approved Standards. NCCLS document M100-S12, Wayne, PA.
32. Odland, B.A., Erwin, M.E. & Jones, R.N. (2000) Quality control guidelines for disk diffusion and broth microdilution antimicrobial susceptibility tests with seven drugs for veterinary applications. Journal of Clinical Microbiology, 38, 453-455.
33. Ose, E.E. (1987) In vitro antibacterial properties of EL-870, a new semisynthetic macrolide antibiotic. Journal of Antibiotics (Tokyo), 40, 190-194.
34. Paradis, M.A., Vessie, G.H., Merrill, J.K. et al. (2004) Efficacy of tilmicosin in the control of experimentally induced Actinobacillus pleuropneumoniae infection in swine. Canadian Journal of Veterinary Research, 68, 7-11.
35. Pillai, S.K., Moellering, R.C. & Eliopoulos, G.M. (2005) Antimicrobial combinations. In Antibiotics in Laboratory Medicine, 5th edn. Ed. Lorian, V. pp. 365-440. Lippincott Williams & Wilkins, Philadelphia.
36. Prescott, J.F. (2000) Lincosamides, macrolides, and pleuromutilins. In Antimicrobial Therapy in Veterinary Medicine, 3rd edn. Eds Prescott, J.F., Baggot, D.J. & Walker, R.D. pp. 229-262. Iowa State University Press, Ames.
37. Ramadan, A. (1997) Pharmacokinetics of tilmicosin in serum and milk of goats. Research in Veterinary Science, 62, 48-50.
38. Rennard, S.I., Basset, G., Lecossier, D., O'Donnell, K.M., Pinkston, P., Martin, P.G. & Crystal, R.G. (1986) Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. Journal of Applied Physiology, 60, 532-538.
39. Retsema, J.A., Bergeron, J.M., Girard, D., Milisen, W.B. & Girard, A.E. (1993) Preferential concentration of azithromycin in an infected mouse thigh model. Journal of Antimicrobial Chemotherapy, 31 (Suppl. E), 5-16.
40. Scorneaux, B. & Shryock, T.R. (1998) Intracellular accumulation, subcellular distribution and efflux of tilmicosin in swine phagocytes. Journal of Veterinary Pharmacology and Therapeutics, 21, 257-268.
41. Scorneaux, B. & Shryock, T.R. (1999) Intracellular accumulation, subcellular distribution, and efflux of tilmicosin in bovine mammary, blood, and lung cells. Journal of Dairy Science, 82, 1202-1212.
42. Shryock, T.R., White, D.W., Staples, J.M. & Werner, C. (1996) Minimum inhibitory concentration breakpoints and disk diffusion inhibitory zone interpretive criteria for tilmicosin susceptibility testing against Pasteurella spp. associated with bovine respiratory disease. Journal of Veterinary Diagnostic and Investigation, 8, 337-344.
43. Stobba-Wiley, C.M., Chang, J.P., Elsbury, D.T., Moran, J.W., Turner, J.M. & Readnour, R.S. (2000) Determination of tilmicosin residues in chicken, cattle, swine and sheep tissue by liquid chromatography. Journal of AOAC International, 83, 837-845.
44. Stratton-Phelps, M., Wilson, W.D. & Gardner, I.A. (2000) Risk of adverse effects in pneumonic foals treated with erythromycin versus other antibiotics: 143 cases (1986-1996). Journal of the American Veterinary Medical Association, 217, 68-73.
45. Ziv, G., Shem-Tov, M., Glickman, A., Winkler, M. & Saran, A. (1995) Tilmicosin antibacterial activity and pharmacokinetics in cows. Journal of Veterinary Pharmacology and Therapeutics, 18, 340-345.